These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2569544)

  • 1. Effects of mafoprazine, a phenylpiperazine derivative, on the central dopaminergic system.
    Yamamura M; Nakagawa H; Maeda K; Kinoshita K; Ishida R
    Jpn J Pharmacol; 1989 Jul; 50(3):295-305. PubMed ID: 2569544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical study of mafoprazine, a new phenylpiperazine derivative.
    Fukuchi I; Kawashima K; Matsuoka Y; Ishida R
    Jpn J Pharmacol; 1988 May; 47(1):51-61. PubMed ID: 3411821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A behavioral pharmacological study of mafoprazine, a new phenylpiperazine derivative.
    Yamamura M; Nakagawa H; Kinoshita K; Ochiai T; Ishida R
    Jpn J Pharmacol; 1988 Oct; 48(2):203-12. PubMed ID: 3210446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.
    Kikuchi T; Tottori K; Uwahodo Y; Hirose T; Miwa T; Oshiro Y; Morita S
    J Pharmacol Exp Ther; 1995 Jul; 274(1):329-36. PubMed ID: 7616416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of clonidine with dopamine-dependent behaviour in rodents.
    Pycock CJ; Jenner PG; Marsden CD
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):133-41. PubMed ID: 558529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroleptic properties of Y-516, a new iminodibenzyl derivative].
    Fukuda T; Setoguchi M; Morimoto Y; Shoji H; Tsumagari T; Maruyama Y
    Nihon Yakurigaku Zasshi; 1985 Sep; 86(3):197-208. PubMed ID: 2867957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
    Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
    Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine receptor agonistic and antagonistic effects of 3-PPP enantiomers.
    Arnt J; Bøgesø KP; Christensen AV; Hyttel J; Larsen JJ; Svendsen O
    Psychopharmacology (Berl); 1983; 81(3):199-207. PubMed ID: 6139838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzamides and classical neuroleptics: comparison of their actions using 6 apomorphine-induced effects.
    Puech AJ; Simon P; Boissier JR
    Eur J Pharmacol; 1978 Aug; 50(4):291-300. PubMed ID: 29758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
    Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity.
    Usuda S; Nishikori K; Noshiro O; Maeno H
    Psychopharmacology (Berl); 1981; 73(2):103-9. PubMed ID: 6112770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of alpha-adrenolytics on central action of agonists and antagonists of dopaminergic system.
    Zebrowska-Lupina I
    Pol J Pharmacol Pharm; 1977; 29(4):393-404. PubMed ID: 20609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral pharmacologic studies in the monkey with DD-3480.
    Shibuya T; Nishimori T; Matsuda H; Chen PC
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):251-4. PubMed ID: 6125481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties.
    Bardin L; Kleven MS; Barret-Grévoz C; Depoortère R; Newman-Tancredi A
    Neuropsychopharmacology; 2006 Sep; 31(9):1869-79. PubMed ID: 16237379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dextromethorphan on dopamine dependent behaviours in rats.
    Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
    Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.
    Cools AR; van Rossum JM
    Life Sci; 1980 Oct; 27(14):1237-53. PubMed ID: 6255271
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic nicotine treatment potentiates behavioral responses to dopaminergic drugs in rats.
    Suemaru K; Gomita Y; Furuno K; Araki Y
    Pharmacol Biochem Behav; 1993 Sep; 46(1):135-9. PubMed ID: 7902980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGYT-2509 a novel neuroleptic agent without extrapyramidal and endocrine side effects.
    Gacsályi I; Petöcz L; Fekete MI; Bükkfálvi B; Görgenyi F; Arató M
    Pol J Pharmacol Pharm; 1988; 40(6):613-9. PubMed ID: 2908364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of buspirone on dopamine dependent behaviours in rats.
    Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
    Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties.
    Oka M; Noda Y; Ochi Y; Furukawa K; Une T; Kurumiya S; Hino K; Karasawa T
    J Pharmacol Exp Ther; 1993 Jan; 264(1):158-65. PubMed ID: 8093723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.